Alison M Goate, DPhil
- PROFESSOR & CHAIR | Genetics and Genomic Sciences
- PROFESSOR | Neuroscience
- PROFESSOR | Neurology
Dr. Alison Goate is a Professor of Neuroscience, and Director of the Ronald Loeb Center for Alzhemier’s Disease.
Her laboratory studies the molecular genetics of dementias and addiction in human populations.
Multi-Disciplinary Training Areas
Genetics and Data Science [GDS], Neuroscience [NEU], Pharmacology and Therapeutics Discovery [PTD]Education
BSc, Hons, University of Bristol
DPhil, Linacre College, University of Oxford
Postdoctoral Research Fellow, Eleanor Roosevelt Institute for Cancer Research
Postdoctoral Research Fellow, Institute of Neurology, University College London
Postdoctoral Research Fellow, St. Mary's Hospital Medical School, Imperial College
-
2020
Keynote Address, Tau 2020, Washington D.C -
2019
Methusalem Lecture, VIB-KU, Center for Brain & Disease Research, Leuven -
2019
Plenary Lecture, 6th Venusberg Meeting on Neuroinflammation (5/9/19) -
2019
DeArmond Lecture American Association of Neuropathologists, Atlanta -
2019
F.E. Bennett Memorial Lectureship, American Neurological Association, St. Louis -
2018
Affiliated Faculty, New York Genome Center (NYGC) -
2016
Elected member of the National Academy of Medicine -
2015
Willard T.C. Johnson Research Professor of Neurogenetics (ISMMS) -
2015
Khalid Iqbal Lifetime Acheivement Award, Alzheimer’s Association -
2015
Blas Frangione Foundation Lecture -
2015
Willard T.C. Johnson Research Professor of Neurogenetics, Professor of Neuroscience, Professor of Neurology, Professor of Genetics & Genomic Sciences -
2015
Director, Ronald Loeb Center for Alzhemier’s Disease -
2015
Associate Director, Alzheimer’s Disease Research Center -
2012
Elected Fellow, American Association for the Advancement of Science -
2005
Carl & Gerty Cori Faculty Achievement Award -
1994
Senior Investigator Award, Metropolitan Life Foundation -
1994
St. Louis Academy of Science Innovation Award -
1993
Potamkin Prize for Alzheimer's disease research -
1993
Zenith Award, Alzheimer's Association -
1989-
Royal Society University Research Fellow
Research in our laboratory focuses on dementia (Alzheimer's disease & frontotemporal dementia) and addiction (alcohol dependence). In each of these projects our goal is to understand the molecular basis of disease in order to identify novel targets for therapeutic development. We use genetic and genomic approaches to identify susceptibility alleles, this work includes integration of multiple levels of OMICs data with genetic data from genome wide association studies and whole genome/exome sequencing in families multiply affected by disease and in case control cohorts. Through these studies we have demonstrated an enrichment of AD risk variants in microglial enhancers. Interestingly variants within the SPI1 (PU.1) locus, a gene which regulates myeloid cell differentiation, influence risk for AD and for alcoholism, demonstrating the importance of neuroimmune communication in both disorders. We are currently pursuing these observations in cell and animal models with the goal of developing PU.1 inhibitors for treatment of AD. In combination with our genetic studies we use induced pluripotent stem cells in vitro and in vivo to study the mechanisms of risk underlying the AD risk genes. To date we have performed functional studies of APOE, SPI1 and MS4A4A/6A in induced microglia. We also have an extensive program studying the functional consequences of MAPT mutations and haplotypes in tauopathies such as PSP and FTD, using iPSC-derived neurons and organoids.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Goate during 2020 and/or 2021. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.
- National Institute of Neurological Disorders and Stroke (NINDS); VIB, Katholic University Leuven; Weill Cornell Medical College
Other Activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership.
- American Association of Neuropathologists; American Neurological Association; BrightFocus; Johns Hopkins University; Sanford Burnham Prebys
Royalty Payments:
- Athena Diagnostics, Inc.; Taconic Biosciences, Inc.
Scientific Advisory Board:
- Columbia University; Indiana University School of Medicine; UK Dementia Research Institute; VIB, Katholic University Leuven; VIB, University of Antwerp; Washington University, St. Louis
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.